Juvenile idiopathic arthritis is a heterogeneous group of diseases characterised by arthritis
of unknown origin with onset before age of 16 years. Pivotal studies in the past 5 years have …

Juvenile idiopathic arthritis (JIA) is defined by the International League of Associations for
Rheumatology (ILAR) as arthritis of unknown etiology that begins before the sixteenth …

Objective To develop treatment recommendations for children with juvenile idiopathic
arthritis manifesting as non‐systemic polyarthritis, sacroiliitis, or enthesitis. Methods The …

Psoriasis is a common chronic immune-mediated inflammatory skin disorder and begins in
childhood in almost one-third of the cases. Although children present with the same clinical …

Objective To prospectively validate the preliminary criteria for clinical inactive disease (CID)
in patients with select categories of juvenile idiopathic arthritis (JIA). Methods We used the …

Objective To determine whether aggressive treatment initiated early in the course of
rheumatoid factor (RF)–positive or RF‐negative polyarticular juvenile idiopathic arthritis (JIA) …

Evidence-based recommendations for vaccination of paediatric patients with rheumatic
diseases (PaedRD) were developed by following the EULAR standardised procedures for …

Objective We previously documented that abatacept was effective and safe in patients with
juvenile idiopathic arthritis (JIA) who had not previously achieved a satisfactory clinical …

Objectives In juvenile idiopathic arthritis (JIA), the efficacy of very early disease-modifying
drug therapy, synthetic or biological, is not well known. Three alternative strategies were …

Objective To compare the incidence of hospitalized bacterial infections among children with
and children without juvenile idiopathic arthritis (JIA) and to examine the effects of selected …